powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1033513619
Wai Wai Lin
MD
Endocrinology
Dover,
DE
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
94.9
Quality
92.9
Cost
0.0
Improvement activities
40.0
Promoting interop.
94.9
Payment adjustment
0.84%
APM Entity
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CCN 490052
Hospital
CCN 490066
Hospital
CCN 490130
Hospital
CCN 490143
Hospital
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$45
Payment records
2
By payment type
Food and Beverage
$45
PRESCRIBING · PART D · 2024
Total Rx claims
649
Beneficiaries
—
Total drug cost
$421K
Distinct drugs
16
Brand share
72.9%
Top prescribed drugs
Semaglutide
125 claims
Insulin Glargine,hum.Rec.Anlog
84 claims
Dulaglutide
64 claims
Levothyroxine Sodium
60 claims
Empagliflozin
41 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
362
Unique beneficiaries
—
Total services
421
Distinct HCPCS
5
Medicare payment
$24K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 21 Endocrinology providers in DE — below median (cohort median 1,131).
